Lisa L. Mathis

521 total citations
9 papers, 341 citations indexed

About

Lisa L. Mathis is a scholar working on Pediatrics, Perinatology and Child Health, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lisa L. Mathis has authored 9 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 5 papers in Economics and Econometrics and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lisa L. Mathis's work include Pharmaceutical studies and practices (8 papers), Pharmaceutical Economics and Policy (5 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Lisa L. Mathis is often cited by papers focused on Pharmaceutical studies and practices (8 papers), Pharmaceutical Economics and Policy (5 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). Lisa L. Mathis collaborates with scholars based in United States, Canada and Thailand. Lisa L. Mathis's co-authors include Debbie Avant, Rosemary Roberts, Robert M. Califf, Jennifer S. Li, Daniel K. Benjamin, M. Dianne Murphy, William Rodriguez, Melissa S. Tassinari, Hari Cheryl Sachs and Shiew‐Mei Huang and has published in prestigious journals such as JAMA, PEDIATRICS and Clinical Pharmacology & Therapeutics.

In The Last Decade

Lisa L. Mathis

9 papers receiving 312 citations

Peers

Lisa L. Mathis
Ruairi M Gallagher United Kingdom
Kim A Bird United Kingdom
Dionna J. Green United States
Samuel Allemann Switzerland
Andrea Linton United States
Louise Bracken United Kingdom
Jennifer R Bellis United Kingdom
Maria Kelly Ireland
Ruairi M Gallagher United Kingdom
Lisa L. Mathis
Citations per year, relative to Lisa L. Mathis Lisa L. Mathis (= 1×) peers Ruairi M Gallagher

Countries citing papers authored by Lisa L. Mathis

Since Specialization
Citations

This map shows the geographic impact of Lisa L. Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa L. Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa L. Mathis more than expected).

Fields of papers citing papers by Lisa L. Mathis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa L. Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa L. Mathis. The network helps show where Lisa L. Mathis may publish in the future.

Co-authorship network of co-authors of Lisa L. Mathis

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa L. Mathis. A scholar is included among the top collaborators of Lisa L. Mathis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa L. Mathis. Lisa L. Mathis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Lind, Jennifer N., Jan M. Friedman, Margaret A. Honein, et al.. (2013). Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web‐based information, 2011. Pharmacoepidemiology and Drug Safety. 22(3). 324–328. 35 indexed citations
2.
Tassinari, Melissa S., et al.. (2011). Monitoring for teratogenic signals: Pregnancy registries and surveillance methods. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 157(3). 209–214. 17 indexed citations
3.
Mathis, Lisa L., et al.. (2011). Pediatric drug development: unmet medical needs and opportunities for collaboration between industry, academia and the US FDA. Clinical Investigation. 1(10). 1345–1347. 1 indexed citations
4.
Mathis, Lisa L. & William Rodriguez. (2009). Drug therapy in pediatrics: a developing field. Dermatologic Therapy. 22(3). 257–261. 7 indexed citations
5.
Benjamin, Daniel K., P. Brian Smith, Meng Sun, et al.. (2009). Safety and Transparency of Pediatric Drug Trials. Archives of Pediatrics and Adolescent Medicine. 163(12). 1080–6. 50 indexed citations
6.
Rodriguez, William, Arzu Selen, Debbie Avant, et al.. (2008). Improving Pediatric Dosing Through Pediatric Initiatives: What We Have Learned. PEDIATRICS. 121(3). 530–539. 114 indexed citations
7.
Mathis, Lisa L. & Solomon Iyasu. (2007). Safety Monitoring of Drugs Granted Exclusivity Under the Best Pharmaceuticals for Children Act: What the FDA has Learned. Clinical Pharmacology & Therapeutics. 82(2). 133–134. 10 indexed citations
8.
Benjamin, Daniel K., M. Dianne Murphy, Rosemary Roberts, et al.. (2006). Peer-Reviewed Publication of Clinical Trials Completed for Pediatric Exclusivity. JAMA. 296(10). 1266–1266. 106 indexed citations
9.
McCune, Susan, Lisa L. Mathis, David M. Cocchetto, Karen L. Ball, & William Rodriguez. (2006). Safer, Better, More Appropriate: Clinical Trial Design for Pediatric Drug Labels. Drug Information Journal. 40(2). 185–195. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026